Oncotype DX Prostate Recurrence Score

The Oncotype DX® Prostate Cancer Assay provides men with newly diagnosed, low-risk prostate cancer and their urologists, critical information to help guide decisions about treatment.

The Oncotype DX Prostate Cancer Assay examines specific genes from a patient’s prostate tumour biopsy, providing individualised information on the biology of their tumour. The activity of these genes influences and regulates the behaviour of the tumour, including whether or not the cancer is likely to grow and spread.

The Oncotype DX Prostate Cancer Assay reports a patient’s Genomic Prostate Score (GPS). The GPS provides important information about how aggressive the cancer is. Used along with other test results, the GPS can help personalise a treatment plan.

The information in the Oncotype DX Prostate Cancer Assay report provides a greater level of confidence when deciding whether to choose active surveillance or to begin immediate treatment with surgery or radiation.

Ordering Oncotype DX in Australia

Please download step-by-step instructions for ordering:

How to Order Oncotype DX in Australia

Please download the required forms:

Click here to complete the Oncotype DX Requisition Form for Colon Cancer or Prostate Cancer

International Pathology Guidelines

Payment Form

For further information on how to order Oncotype DX, please contact Specialised Therapeutics on:

Phone: 1300 798 820 or +61 3 9859 1493

Email: customerservice@stbiopharma.com

Fax: 1800 798 829 or +61 3 9859 6950

Further information regarding the Oncotype DX Breast Cancer Assay can also be found on the Oncotype DX website, hosted by Genomic Health, Inc.

Oncotype DX® and Recurrence Score® are registered trademarks of Genomic Health, Inc. Oncotype DX® is under license from Genomic Health Inc.